FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Erlotinib Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Astellas Pharma Global Development, Inc. (New 09/29/2020)

Company Contact Information:
800-727-7003

Presentation Posting Date Related Information
25 mg tablets (NDC 50242-062-01) 09/29/2020
100 mg tablets (NDC 50242-063-01) 09/29/2020
150 mg tablets (NDC 50242-064-01) 09/29/2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English